OKX Announces Sponsorship of Key Events at India Blockchain Week, Will Co-Host Developer Events Showcasing Web3 Innovations

BANGALORE, India, Dec. 04, 2023 (GLOBE NEWSWIRE) — OKX, a leading Web3 technology company, today announced its sponsorship of key events at India Blockchain Week (IBW), which takes place from December 4-10 at Sheraton Grand Whitefield, Bangalore. During the week, OKX will sponsor Polygon Connect on December 7 and ETH India from Dec 8-10, and […]

Read More »

A21 Expands Anti-Trafficking Initiatives in Southeast Asia with Key Events in Thailand and Cambodia

A21 Thailand Child Advocacy Center Conference Room PATTAYA, Thailand, Dec. 03, 2023 (GLOBE NEWSWIRE) — A21, a global nonprofit organization committed to eradicating human trafficking through awareness, intervention, and aftercare, is proud to announce two landmark events in Pattaya, Thailand, and Cambodia. These initiatives underscore A21’s ongoing dedication to fortifying and expanding anti-trafficking efforts across […]

Read More »

Exhibition World Bahrain Secures “World’s Leading New Exhibition and Convention Centre 2023” Award at World Travel Awards 2023

Exhibition World Bahrain Secures “World’s Leading New Exhibition and Convention Centre 2023” Award at World Travel Awards 2023 DUBAI, United Arab Emirates, Dec. 03, 2023 (GLOBE NEWSWIRE) — Exhibition World Bahrain (EWB), the Middle East’s newest and largest exhibition and convention centre, is proud to announce securing the “World’s Leading New Exhibition and Convention Centre […]

Read More »

CASGEVY Gets Bahrain approval for treatment, marking it second country in the world

MANAMA, Bahrain, Dec. 02, 2023 (GLOBE NEWSWIRE) — Bahrain has become the second country in the world and the first in the Middle East to approve the use of CASGEVY (exagamglogene autotemcel) for the treatment of patients with sickle cell disease and transfusion-dependent beta-thalassemia. The treatment was developed by Vertex Pharmaceuticals and CRISPR Therapeutics, after […]

Read More »

Junshi Biosciences Announces New Chemical Entity Application for Toripalimab Accepted by Australia’s TGA

SHANGHAI, China, Dec. 01, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Therapeutic Goods Administration of the Australian Government Department of Health and Aged Care (TGA) has accepted the New […]

Read More »